Literature DB >> 12393284

PCOLCE deletion and expression analyses in uterine leiomyomata.

Azra H Ligon1, Ian C Scott, Kazuhiko Takahara, Daniel S Greenspan, Cynthia C Morton.   

Abstract

Uterine leiomyomata (UL) are benign tumors affecting many women of reproductive age. Cytogenetic studies have indicated that a significant percentage of leiomyomata have chromosomal rearrangements, including those involving the long arm of chromosome 7. Several candidate genes that map to chromosome 7 have been studied for possible roles in the pathogenesis of these tumors. PCOLCE, a gene whose product is involved in the cleavage of type I procollagen C-propeptide, has been mapped to the critical interval on chromosome 7, band q22. Here we evaluate by reverse-transcriptase polymerase chain reaction (RT-PCR) and fluorescence in situ hybridization the expression and deletion status of PCOLCE in a series of karyotyped uterine leiomyomata.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393284     DOI: 10.1016/s0165-4608(02)00547-2

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

1.  Detection of novel copy number variants in uterine leiomyomas using high-resolution SNP arrays.

Authors:  Wayne Bowden; Josh Skorupski; Ertug Kovanci; Aleksandar Rajkovic
Journal:  Mol Hum Reprod       Date:  2009-06-30       Impact factor: 4.025

Review 2.  Macrophages and Immune Responses in Uterine Fibroids.

Authors:  Alessandro Zannotti; Stefania Greco; Pamela Pellegrino; Federica Giantomassi; Giovanni Delli Carpini; Gaia Goteri; Andrea Ciavattini; Pasquapina Ciarmela
Journal:  Cells       Date:  2021-04-22       Impact factor: 6.600

3.  A Possible Cause for the Differential Expression of a Subset of miRNAs in Mesenchymal Stem Cells Derived from Myometrium and Leiomyoma.

Authors:  Mariangela Di Vincenzo; Concetta De Quattro; Marzia Rossato; Raffaella Lazzarini; Giovanni Delli Carpini; Andrea Ciavattini; Monia Orciani
Journal:  Genes (Basel)       Date:  2022-06-21       Impact factor: 4.141

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.